HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1201	25613 Schmidt AL, Brunetto AL, Schwartsmann G, Roesler R, Abujamra AL Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 335-348	0	0	33	179
1202	1053 HALIOUA B, ORTONNE JP NEURO-ENDOCRINE CARCINOMA OF THE SKIN ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. 1988; 115 (12): 1305-1322	3	13	9	178
1203	6551 Tilley L, Morgan K, Kalsheker N Genetic risk factors in Alzheimer's disease JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY. 1998 DEC; 51 (6): 293-304	6	33	10	178
1204	7933 Stevanin G, Durr A, Brice A Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology EUROPEAN JOURNAL OF HUMAN GENETICS. 2000 JAN; 8 (1): 4-18	7	74	18	178
1205	8283 Evidente VGH, Gwinn-Hardy KA, Caviness JN, Gilman S Hereditary ataxias MAYO CLINIC PROCEEDINGS. 2000 MAY; 75 (5): 475-490	2	41	6	178
1206	10108 Lee MK, Price DL Advances in genetic models of Parkinson's disease CLINICAL NEUROSCIENCE RESEARCH. 2001 DEC; 1 (6): 456-466	5	8	59	178
1207	10129 Ramsden DB, Parsons RB, Ho SL, Waring RH The aetiology of idiopathic Parkinson's disease JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY. 2001 DEC; 54 (6): 369-380	6	7	29	178
1208	10787 Grossman M Frontotemporal dementia: A review JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY. 2002 MAY; 8 (4): 566-583	42	71	22	178
1209	11666 Bonini NM, Fortini ME Human neurodegenerative disease modeling using Drosophila ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 627-656	26	66	58	178
1210	15070 Walsh K, Megyesi J, Hammond R Human central nervous system tissue culture: a historical review and examination of recent advances NEUROBIOLOGY OF DISEASE. 2005 FEB; 18 (1): 2-18	1	15	20	178
#	Date / Author / Journal	LCS	GCS	LCR	CR
1211	15149 Craddock N, O'Donovan MC, Owen MJ The genetics of schizophrenia and bipolar disorder: dissecting psychosis JOURNAL OF MEDICAL GENETICS. 2005 MAR; 42 (3): 193-204	14	214	4	178
1212	15286 Marambaud P, Robakis NK Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation GENES BRAIN AND BEHAVIOR. 2005 APR; 4 (3): 134-146	5	33	22	178
1213	16436 Leuchtenberger S, Beher D, Weggen S Selective modulation of A beta 42 production in Alzheimer's disease: Non-steroidal anti-inflammatory drugs and beyond CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4337-4355	4	19	14	178
1214	16441 Churcher I Tau therapeutic strategies for the treatment of Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 579-595	28	49	76	178
1215	17034 Jimenez-Jimenez FJ, Alonso-Navarro H, Ayuso-Peralta L, Jabbour-Wadih T Oxidative stress and Alzheimer's disease REVISTA DE NEUROLOGIA. 2006 APR 1; 42 (7): 419-427	0	2	22	178
1216	17626 Berg D, Hochstrasser H Iron metabolism in parkinsonian syndromes MOVEMENT DISORDERS. 2006 SEP; 21 (9): 1299-1310	6	35	21	178
1217	17645 Nawa H, Takei N Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines NEUROSCIENCE RESEARCH. 2006 SEP; 56 (1): 2-13	3	49	10	178
1218	20109 Crouch PJ, Harding SME, White AR, Camakaris J, Bush AI, et al. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2008; 40 (2): 181-198	12	53	23	178
1219	21225 Mizuno Y, Hattori N, Kubo SI, Sato S, Nishioka K, et al. Progress in the pathogenesis and genetics of Parkinson's disease PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 JUN 27; 363 (1500): 2215-2227	5	14	48	178
1220	21478 Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, et al. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models FREE RADICAL BIOLOGY AND MEDICINE. 2008 AUG 1; 45 (3): 219-230	6	18	61	178
#	Date / Author / Journal	LCS	GCS	LCR	CR
1221	22216 Salmina AB Neuron-Glia Interactions as Therapeutic Targets in Neurodegeneration JOURNAL OF ALZHEIMERS DISEASE. 2009; 16 (3): 485-502	1	14	13	178
1222	22426 Schaeffer EL, Forlenza OV, Gattaz WF Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease PSYCHOPHARMACOLOGY. 2009 JAN; 202 (1-3): 37-51	0	4	8	178
1223	24508 Takeda M, Martinez R, Kudo T, Tanaka T, Okochi M, et al. Apolipoprotein E and central nervous system disorders: Reviews of clinical findings PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2010; 64 (6): 592-607	0	0	28	178
1224	24527 Boeve BF REM sleep behavior disorder Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions YEAR IN NEUROLOGY 2. 2010; 1184: 15-54	1	5	32	178
1225	24575 Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: Evidence for A beta(25-35) EXPERIMENTAL NEUROLOGY. 2010 JAN; 221 (1): 26-37	0	5	14	178
1226	24635 Northcott PA, Rutka JT, Taylor MD Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years NEUROSURGICAL FOCUS. 2010 JAN; 28 (1): Art. No. E6	0	2	19	178
1227	26735 Kim HJ Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2011 JAN; 1812 (1): 1-11	0	1	22	178
1228	133 MANN MD SETS OF NEURONS IN SOMATIC CEREBRAL-CORTEX OF THE CAT AND THEIR ONTOGENY BRAIN RESEARCH REVIEWS. 1979; 1 (1): 3-45	0	16	6	177
1229	4814 Jones EG Cortical development and thalamic pathology in schizophrenia SCHIZOPHRENIA BULLETIN. 1997; 23 (3): 483-501	11	134	11	177
1230	7810 Lee VMY, Trojanowski JQ Distinct tau gene mutations induce specific dysfunctions/toxic properties in tau proteins associated with specific FTDP-17 phenotypes FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 87-104	1	1	108	177
#	Date / Author / Journal	LCS	GCS	LCR	CR
1231	8627 McCaffery P, Drager UC Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor CYTOKINE & GROWTH FACTOR REVIEWS. 2000 SEP; 11 (3): 233-249	4	94	2	177
1232	10110 Bowers WJ, Maguire-Zeiss KA, Harvey BK, Federoff HJ Gene therapeutic approaches to the treatment of Parkinson's disease CLINICAL NEUROSCIENCE RESEARCH. 2001 DEC; 1 (6): 483-495	1	2	26	177
1233	16839 Cullinan SB, Diehl JA Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2006 MAR; 38 (3): 317-332	2	59	7	177
1234	18958 O'Neill MJ, Witkin JM AMPA receptor potentiators: Application for depression and Parkinson's disease CURRENT DRUG TARGETS. 2007 MAY; 8 (5): 603-620	2	26	14	177
1235	19584 Emre M, Aarsland D, Brown R, Bum DJ, Duyckaerts C, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease MOVEMENT DISORDERS. 2007 SEP 15; 22 (12): 1689-1707	91	169	29	177
1236	21156 Puglielli L Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit? NEUROBIOLOGY OF AGING. 2008 JUN; 29 (6): 795-811	3	20	13	177
1237	22931 Lesage S, Brice A Parkinson's disease: from monogenic forms to genetic susceptibility factors HUMAN MOLECULAR GENETICS. 2009 APR 15; 18: R48-R59	26	71	39	177
1238	23113 Olgiati P, Mandelli L, Lorenzi C, Marino E, Adele P, et al. Schizophrenia: genetics, prevention and rehabilitation ACTA NEUROPSYCHIATRICA. 2009 JUN; 21 (3): 109-120	0	0	17	177
1239	23253 Zilka N, Korenova M, Novak M Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 71-86	7	9	104	177
1240	24014 Dion PA, Daoud H, Rouleau GA Genetics of motor neuron disorders: new insights into pathogenic mechanisms NATURE REVIEWS GENETICS. 2009 NOV; 10 (11): 769-782	10	33	30	177
#	Date / Author / Journal	LCS	GCS	LCR	CR
1241	24275 Feng LR, Maguire-Zeiss KA Gene Therapy in Parkinson's Disease Rationale and Current Status CNS DRUGS. 2010; 24 (3): 177-192	0	2	37	177
1242	24566 De Kimpe L, Scheper W From Alpha to Omega with A beta: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimer's Disease CURRENT MEDICINAL CHEMISTRY. 2010 JAN; 17 (3): 198-212	0	2	38	177
1243	25331 Miranda HV, Outeiro TF The sour side of neurodegenerative disorders: the effects of protein glycation JOURNAL OF PATHOLOGY. 2010 MAY; 221 (1): 13-25	0	3	39	177
1244	25786 Otzen DE Amyloid Formation in Surfactants and Alcohols: Membrane Mimetics or Structural Switchers? CURRENT PROTEIN & PEPTIDE SCIENCE. 2010 AUG; 11 (5): 355-371	1	1	21	177
1245	162 LYNCH JC THE FUNCTIONAL-ORGANIZATION OF POSTERIOR PARIETAL ASSOCIATION CORTEX BEHAVIORAL AND BRAIN SCIENCES. 1980; 3 (4): 485-499	24	251	5	176
1246	3075 ERLANDSON RA, NESLAND JM TUMORS OF THE ENDOCRINE/NEUROENDOCRINE SYSTEM - AN OVERVIEW ULTRASTRUCTURAL PATHOLOGY. 1994 JAN-APR; 18 (1-2): 149-170	0	18	4	176
1247	7166 Kilpatrick TJ, Soilu-Hanninen M Molecular mechanisms regulating motor neuron development and degeneration MOLECULAR NEUROBIOLOGY. 1999 JUN; 19 (3): 205-228	2	7	17	176
1248	8098 Middleton FA, Strick PL Basal ganglia and cerebellar loops: motor and cognitive circuits BRAIN RESEARCH REVIEWS. 2000 MAR; 31 (2-3): 236-250	5	532	7	176
1249	9704 Sanchez MP, Alvarez-Tallada V, Avila J The microtubule associated protein tau in neurodegenerative diseases. Tauopathies REVISTA DE NEUROLOGIA. 2001 JUL 16; 33 (2): 169-177	2	5	92	176
1250	9951 Venters HD, Broussard SR, Zhou JH, Bluthe RM, Freund GG, et al. Tumor necrosis factor alpha and insulin-like growth factor-I in the brain: Is the whole greater than the sum of its parts? JOURNAL OF NEUROIMMUNOLOGY. 2001 OCT 1; 119 (2): 151-165	3	20	5	176
#	Date / Author / Journal	LCS	GCS	LCR	CR
1251	13947 Park E, Velumian AA, Fehlings MG The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration JOURNAL OF NEUROTRAUMA. 2004 JUN; 21 (6): 754-774	6	121	17	176
1252	16000 Lazic SE, Barker RA Cell-based therapies for disorders of the CNS EXPERT OPINION ON THERAPEUTIC PATENTS. 2005 OCT; 15 (10): 1361-1376	0	1	15	176
1253	16431 Herbst M, Wanker EE Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2543-2555	6	11	42	176
1254	18174 Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D Treatment of dementia in Parkinsonian syndromes with cholinesterase inhibitors DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007; 23 (6): 351-367	1	2	40	176
1255	18853 Giordano V, Peluso G, Iannuccelli M, Benatti P, Nicolai R, et al. Systemic and brain metabolic dysfunction as a new paradigm for approaching alzheimer's dementia NEUROCHEMICAL RESEARCH. 2007 APR; 32 (4-5): 555-567	0	8	9	176
1256	18973 Hipkiss AR Could carnosine or related structures suppress Alzheimer's disease? JOURNAL OF ALZHEIMERS DISEASE. 2007 MAY; 11 (2): 229-240	1	23	18	176
1257	21273 Naylor R, Richardson SJ, McAllan BM Boom and bust: a review of the physiology of the marsupial genus Antechinus JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY. 2008 JUL; 178 (5): 545-562	0	3	7	176
1258	23136 Camins A, Crespo-Biel N, Junyent F, Verdaguer E, Canudas AM, et al. Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium CURRENT DRUG METABOLISM. 2009 JUN; 10 (5): 433-447	1	3	18	176
1259	23419 Tovar-Y-Romo LB, Santa-Cruz LD, Tapia R Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis MOLECULAR NEURODEGENERATION. 2009 JUL 20; 4: Art. No. 31	0	0	27	176
1260	23606 Tan JMM, Wong ESP, Lim KL Protein Misfolding and Aggregation in Parkinson's Disease ANTIOXIDANTS & REDOX SIGNALING. 2009 SEP; 11 (9): 2119-2134	5	10	101	176
#	Date / Author / Journal	LCS	GCS	LCR	CR
1261	25105 Kim EK, Choi EJ Pathological roles of MAPK signaling pathways in human diseases BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 APR; 1802 (4): 396-405	0	22	48	176
1262	26544 Souter S, Lee G Tubulin-Independent Tau in Alzheimer's Disease and Cancer: Implications for Disease Pathogenesis and Treatment CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 697-707	1	1	73	176
1263	3905 HAAG ML, GLASS LF, FENSKE NA MERKEL CELL-CARCINOMA - DIAGNOSIS AND TREATMENT DERMATOLOGIC SURGERY. 1995 AUG; 21 (8): 669-683	1	97	12	175
1264	3930 IACANGELO AL, EIDEN LE CHROMOGRANIN-A - CURRENT STATUS AS A PRECURSOR FOR BIOACTIVE PEPTIDES AND A GRANULOGENIC/SORTING FACTOR IN THE REGULATED SECRETORY PATHWAY REGULATORY PEPTIDES. 1995 AUG 22; 58 (3): 65-88	6	111	22	175
1265	6102 Prusiner SB The prion diseases BRAIN PATHOLOGY. 1998 JUL; 8 (3): 499-513	22	137	4	175
1266	9110 Dodel RC, Berger K, Oertel WH Health-related quality of life and healthcare utilisation in patients with Parkinson's disease - Impact of motor fluctuations and dyskinesias PHARMACOECONOMICS. 2001; 19 (10): 1013-1038	0	47	4	175
1267	9925 Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, et al. Brain iron pathways and their relevance to Parkinson's disease JOURNAL OF NEUROCHEMISTRY. 2001 OCT; 79 (2): 225-236	26	163	8	175
1268	10478 Borriello A, Roberto R, Della Ragione F, Iolascon A Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma HAEMATOLOGICA. 2002 FEB; 87 (2): 196-214	0	28	7	175
1269	13242 Rodrigo J, Fernandez-Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, et al. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice NEUROSCIENCE. 2004; 128 (1): 73-89	12	43	28	175
1270	14190 Vekrellis K, Rideout HJ, Stefanis L Neurobiology of alpha-synulein MOLECULAR NEUROBIOLOGY. 2004 AUG; 30 (1): 1-21	32	42	140	175
#	Date / Author / Journal	LCS	GCS	LCR	CR
1271	14390 Eberhardt O, Schulz JB Gene therapy in Parkinson's disease CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 243-260	0	3	18	175
1272	18523 Lehericy S, Marjanska M, Mesrob L, Sarazin M, Kinkingnehun S Magnetic resonance imaging of Alzheimer's disease EUROPEAN RADIOLOGY. 2007 FEB; 17 (2): 347-362	4	21	13	175
1273	22200 Bakota L, Brandt R LIVE-CELL IMAGING IN THE STUDY OF NEURODEGENERATION INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 276. 2009; 276: 49-103	1	2	32	175
1274	22414 Manciocco A, Chiarotti F, Vitale A, Calamandrei G, Laviola G, et al. The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: The case of Parkinson's disease NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2009 JAN; 33 (1): 18-32	1	2	20	175
1275	23195 Sanchez-Moreno C, Jimenez-Escrig A, Martin A Stroke: roles of B vitamins, homocysteine and antioxidants NUTRITION RESEARCH REVIEWS. 2009 JUN; 22 (1): 49-67	0	5	3	175
1276	23466 Bamburg JR, Bloom GS Cytoskeletal Pathologies of Alzheimer Disease CELL MOTILITY AND THE CYTOSKELETON. 2009 AUG; 66 (8): 635-649	5	8	43	175
1277	24284 Castro RE, Santos MMM, Gloria PMC, Ribeiro CJA, Ferreira DMS, et al. Cell Death Targets and Potential Modulators in Alzheimer's Disease CURRENT PHARMACEUTICAL DESIGN. 2010; 16 (25): 2851-2864	0	0	15	175
1278	24504 Kikis EA, Gidalevitz T, Morimoto RI Protein Homeostasis in Models of Aging and Age-Related Conformational Disease PROTEIN METABOLISM AND HOMEOSTASIS IN AGING. 2010; 694: 138-159	0	0	30	175
1279	25137 Nilsson P, Iwata N, Muramatsu S, Tjernberg LO, Winblad B, et al. Gene therapy in Alzheimer's disease - potential for disease modification JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2010 APR; 14 (4): 741-757	0	1	15	175
1280	416 CROWNE DP THE FRONTAL EYE FIELD AND ATTENTION PSYCHOLOGICAL BULLETIN. 1983; 93 (2): 232-260	5	69	7	174
#	Date / Author / Journal	LCS	GCS	LCR	CR
1281	1843 CAMERON RS, RAKIC P GLIAL-CELL LINEAGE IN THE CEREBRAL-CORTEX - A REVIEW AND SYNTHESIS GLIA. 1991; 4 (2): 124-137	11	330	2	174
1282	4277 AbiDargham A, Laruelle M, Charney D, Krystal J Serotonin and schizophrenia: A review DRUGS OF TODAY. 1996 MAR; 32 (2): 171-185	0	8	4	174
1283	9121 Maynard TM, Sikich L, Lieberman JA, LaMantia AS Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia SCHIZOPHRENIA BULLETIN. 2001; 27 (3): 457-476	3	43	12	174
1284	9271 Sieradzan KA, Mann DMA The selective vulnerability of nerve cells in Huntington's disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2001 FEB; 27 (1): 1-21	9	64	43	174
1285	9935 Chiesa R, Harris DA Prion diseases: What is the neurotoxic molecule? NEUROBIOLOGY OF DISEASE. 2001 OCT; 8 (5): 743-763	9	98	18	174
1286	11520 Coppens P, Hungerford S, Yamaguchi S, Yamadori A Crossed aphasia: An analysis of the symptoms, their frequency, and a comparison with left-hemisphere aphasia symptomatology BRAIN AND LANGUAGE. 2002 DEC; 83 (3): 425-463	0	13	13	174
1287	13037 Britz-Cunningham SH, Adelstein SJ Molecular targeting with radionuclides: State of the science JOURNAL OF NUCLEAR MEDICINE. 2003 DEC; 44 (12): 1945-1961	0	53	5	174
1288	13598 Tuo JS, Bojanowski CM, Chan CC Genetic factors of age-related macular degeneration PROGRESS IN RETINAL AND EYE RESEARCH. 2004 MAR; 23 (2): 229-249	1	39	2	174
1289	15297 Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease JOURNAL OF CLINICAL NEUROSCIENCE. 2005 APR; 12 (3): 221-230	11	17	42	174
1290	16655 Beda NV, Nedospasov AA Inorganic nitric oxide metabolites participating in NO-dependent modifications of biopolymers RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY. 2006 JAN-FEB; 32 (1): 1-22	0	3	4	174
#	Date / Author / Journal	LCS	GCS	LCR	CR
1291	17896 Barbas NR Cognitive, affective, and psychiatric features of Parkinson's disease CLINICS IN GERIATRIC MEDICINE. 2006 NOV; 22 (4): 773-+	2	12	30	174
1292	17898 Huang HC, Klein PS Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease CURRENT DRUG TARGETS. 2006 NOV; 7 (11): 1389-1397	6	30	45	174
1293	18020 Marsh ED, Brooks-Kayal AR, Porter BE Seizures and antiepileptic drugs: Does exposure alter normal brain development ? EPILEPSIA. 2006 DEC; 47 (12): 1999-2010	1	15	4	174
1294	19252 Tan EK, Skipper LM Pathogenic mutations in Parkinson disease HUMAN MUTATION. 2007 JUL; 28 (7): 641-653	16	70	63	174
1295	19282 Bohnen NI, Frey KA Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders MOLECULAR IMAGING AND BIOLOGY. 2007 JUL-AUG; 9 (4): 243-257	2	9	7	174
1296	20479 Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA Polymeric nanoparticles for the drug delivery to the central nervous system EXPERT OPINION ON DRUG DELIVERY. 2008 FEB; 5 (2): 155-174	0	26	3	174
1297	22804 Nakamura T, Lipton SA Cell death: protein misfolding and neurodegenerative diseases APOPTOSIS. 2009 APR; 14 (4): 455-468	5	31	40	174
1298	23379 Mueller S, Chang S Pediatric Brain Tumors: Current Treatment Strategies and Future Therapeutic Approaches NEUROTHERAPEUTICS. 2009 JUL; 6 (3): 570-586	1	6	17	174
1299	160 WURTZ RH, ALBANO JE VISUAL-MOTOR FUNCTION OF THE PRIMATE SUPERIOR COLLICULUS ANNUAL REVIEW OF NEUROSCIENCE. 1980; 3: 189-226	16	404	8	173
1300	972 DAMJANOV I LECTIN CYTOCHEMISTRY AND HISTOCHEMISTRY LABORATORY INVESTIGATION. 1987 JUL; 57 (1): 5-20	2	393	4	173

Date / Author / Journal

LCS

GCS

LCR

1201

25613 Schmidt AL, Brunetto AL, Schwartsmann G, Roesler R, Abujamra AL

Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 335-348

179

1202

1053 HALIOUA B, ORTONNE JP

NEURO-ENDOCRINE CARCINOMA OF THE SKIN

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. 1988; 115 (12): 1305-1322

178

1203

6551 Tilley L, Morgan K, Kalsheker N

Genetic risk factors in Alzheimer's disease

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY. 1998 DEC; 51 (6): 293-304

178

1204

7933 Stevanin G, Durr A, Brice A

Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology

EUROPEAN JOURNAL OF HUMAN GENETICS. 2000 JAN; 8 (1): 4-18

178

1205

8283 Evidente VGH, Gwinn-Hardy KA, Caviness JN, Gilman S

Hereditary ataxias

MAYO CLINIC PROCEEDINGS. 2000 MAY; 75 (5): 475-490

178

1206

10108 Lee MK, Price DL

Advances in genetic models of Parkinson's disease

CLINICAL NEUROSCIENCE RESEARCH. 2001 DEC; 1 (6): 456-466

178

1207

10129 Ramsden DB, Parsons RB, Ho SL, Waring RH

The aetiology of idiopathic Parkinson's disease

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY. 2001 DEC; 54 (6): 369-380

178

1208

10787 Grossman M

Frontotemporal dementia: A review

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY. 2002 MAY; 8 (4): 566-583

178

1209

11666 Bonini NM, Fortini ME

Human neurodegenerative disease modeling using Drosophila

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 627-656

178

1210

15070 Walsh K, Megyesi J, Hammond R

Human central nervous system tissue culture: a historical review and examination of recent advances

NEUROBIOLOGY OF DISEASE. 2005 FEB; 18 (1): 2-18

178

Date / Author / Journal

LCS

GCS

LCR

1211

15149 Craddock N, O'Donovan MC, Owen MJ

The genetics of schizophrenia and bipolar disorder: dissecting psychosis

JOURNAL OF MEDICAL GENETICS. 2005 MAR; 42 (3): 193-204

214

178

1212

15286 Marambaud P, Robakis NK

Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation

GENES BRAIN AND BEHAVIOR. 2005 APR; 4 (3): 134-146

178

1213

16436 Leuchtenberger S, Beher D, Weggen S

Selective modulation of A beta 42 production in Alzheimer's disease: Non-steroidal anti-inflammatory drugs and beyond

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4337-4355

178

1214

16441 Churcher I

Tau therapeutic strategies for the treatment of Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 579-595

178

1215

17034 Jimenez-Jimenez FJ, Alonso-Navarro H, Ayuso-Peralta L, Jabbour-Wadih T

Oxidative stress and Alzheimer's disease

REVISTA DE NEUROLOGIA. 2006 APR 1; 42 (7): 419-427

178

1216

17626 Berg D, Hochstrasser H

Iron metabolism in parkinsonian syndromes

MOVEMENT DISORDERS. 2006 SEP; 21 (9): 1299-1310

178

1217

17645 Nawa H, Takei N

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines

NEUROSCIENCE RESEARCH. 2006 SEP; 56 (1): 2-13

178

1218

20109 Crouch PJ, Harding SME, White AR, Camakaris J, Bush AI, et al.

Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2008; 40 (2): 181-198

178

1219

21225 Mizuno Y, Hattori N, Kubo SI, Sato S, Nishioka K, et al.

Progress in the pathogenesis and genetics of Parkinson's disease

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 JUN 27; 363 (1500): 2215-2227

178

1220

21478 Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, et al.

Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

FREE RADICAL BIOLOGY AND MEDICINE. 2008 AUG 1; 45 (3): 219-230

178

Date / Author / Journal

1221

Neuron-Glia Interactions as Therapeutic Targets in Neurodegeneration

JOURNAL OF ALZHEIMERS DISEASE. 2009; 16 (3): 485-502

178

1222

22426 Schaeffer EL, Forlenza OV, Gattaz WF

Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

PSYCHOPHARMACOLOGY. 2009 JAN; 202 (1-3): 37-51

178

1223

24508 Takeda M, Martinez R, Kudo T, Tanaka T, Okochi M, et al.

Apolipoprotein E and central nervous system disorders: Reviews of clinical findings

PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2010; 64 (6): 592-607

178

1224

24527 Boeve BF

REM sleep behavior disorder Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions

YEAR IN NEUROLOGY 2. 2010; 1184: 15-54

178

1225

24575 Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA

Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: Evidence for A beta(25-35)

EXPERIMENTAL NEUROLOGY. 2010 JAN; 221 (1): 26-37

178

1226

24635 Northcott PA, Rutka JT, Taylor MD

Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years

NEUROSURGICAL FOCUS. 2010 JAN; 28 (1): Art. No. E6

178

1227

26735 Kim HJ

Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2011 JAN; 1812 (1): 1-11

178

1228

133 MANN MD

SETS OF NEURONS IN SOMATIC CEREBRAL-CORTEX OF THE CAT AND THEIR ONTOGENY

BRAIN RESEARCH REVIEWS. 1979; 1 (1): 3-45

177

1229

4814 Jones EG

Cortical development and thalamic pathology in schizophrenia

SCHIZOPHRENIA BULLETIN. 1997; 23 (3): 483-501

134

177

1230

7810 Lee VMY, Trojanowski JQ

Distinct tau gene mutations induce specific dysfunctions/toxic properties in tau proteins associated with specific FTDP-17 phenotypes

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 87-104

108

177

Date / Author / Journal

LCS

GCS

LCR

1231

8627 McCaffery P, Drager UC

Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor

CYTOKINE & GROWTH FACTOR REVIEWS. 2000 SEP; 11 (3): 233-249

177

1232

10110 Bowers WJ, Maguire-Zeiss KA, Harvey BK, Federoff HJ

Gene therapeutic approaches to the treatment of Parkinson's disease

CLINICAL NEUROSCIENCE RESEARCH. 2001 DEC; 1 (6): 483-495

177

1233

16839 Cullinan SB, Diehl JA

Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2006 MAR; 38 (3): 317-332

177

1234

18958 O'Neill MJ, Witkin JM

AMPA receptor potentiators: Application for depression and Parkinson's disease

CURRENT DRUG TARGETS. 2007 MAY; 8 (5): 603-620

177

1235

19584 Emre M, Aarsland D, Brown R, Bum DJ, Duyckaerts C, et al.

Clinical diagnostic criteria for dementia associated with Parkinson's disease

MOVEMENT DISORDERS. 2007 SEP 15; 22 (12): 1689-1707

169

177

1236

21156 Puglielli L

Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?

NEUROBIOLOGY OF AGING. 2008 JUN; 29 (6): 795-811

177

1237

22931 Lesage S, Brice A

Parkinson's disease: from monogenic forms to genetic susceptibility factors

HUMAN MOLECULAR GENETICS. 2009 APR 15; 18: R48-R59

177

1238

23113 Olgiati P, Mandelli L, Lorenzi C, Marino E, Adele P, et al.

Schizophrenia: genetics, prevention and rehabilitation

ACTA NEUROPSYCHIATRICA. 2009 JUN; 21 (3): 109-120

177

1239

23253 Zilka N, Korenova M, Novak M

Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies

ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 71-86

104

177

1240

24014 Dion PA, Daoud H, Rouleau GA

Genetics of motor neuron disorders: new insights into pathogenic mechanisms

NATURE REVIEWS GENETICS. 2009 NOV; 10 (11): 769-782

177

Date / Author / Journal

LCS

GCS

LCR

1241

24275 Feng LR, Maguire-Zeiss KA

Gene Therapy in Parkinson's Disease Rationale and Current Status

CNS DRUGS. 2010; 24 (3): 177-192

177

1242

24566 De Kimpe L, Scheper W

From Alpha to Omega with A beta: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimer's Disease

CURRENT MEDICINAL CHEMISTRY. 2010 JAN; 17 (3): 198-212

177

1243

25331 Miranda HV, Outeiro TF

The sour side of neurodegenerative disorders: the effects of protein glycation

JOURNAL OF PATHOLOGY. 2010 MAY; 221 (1): 13-25

177

1244

25786 Otzen DE

Amyloid Formation in Surfactants and Alcohols: Membrane Mimetics or Structural Switchers?

CURRENT PROTEIN & PEPTIDE SCIENCE. 2010 AUG; 11 (5): 355-371

177

1245

162 LYNCH JC

THE FUNCTIONAL-ORGANIZATION OF POSTERIOR PARIETAL ASSOCIATION CORTEX

BEHAVIORAL AND BRAIN SCIENCES. 1980; 3 (4): 485-499

251

176

1246

3075 ERLANDSON RA, NESLAND JM

TUMORS OF THE ENDOCRINE/NEUROENDOCRINE SYSTEM - AN OVERVIEW

ULTRASTRUCTURAL PATHOLOGY. 1994 JAN-APR; 18 (1-2): 149-170

176

1247

7166 Kilpatrick TJ, Soilu-Hanninen M

Molecular mechanisms regulating motor neuron development and degeneration

MOLECULAR NEUROBIOLOGY. 1999 JUN; 19 (3): 205-228

176

1248

8098 Middleton FA, Strick PL

Basal ganglia and cerebellar loops: motor and cognitive circuits

BRAIN RESEARCH REVIEWS. 2000 MAR; 31 (2-3): 236-250

532

176

1249

9704 Sanchez MP, Alvarez-Tallada V, Avila J

The microtubule associated protein tau in neurodegenerative diseases. Tauopathies

REVISTA DE NEUROLOGIA. 2001 JUL 16; 33 (2): 169-177

176

1250

9951 Venters HD, Broussard SR, Zhou JH, Bluthe RM, Freund GG, et al.

Tumor necrosis factor alpha and insulin-like growth factor-I in the brain: Is the whole greater than the sum of its parts?

JOURNAL OF NEUROIMMUNOLOGY. 2001 OCT 1; 119 (2): 151-165

176

Date / Author / Journal

LCS

GCS

LCR

1251

13947 Park E, Velumian AA, Fehlings MG

The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration

JOURNAL OF NEUROTRAUMA. 2004 JUN; 21 (6): 754-774

121

176

1252

16000 Lazic SE, Barker RA

Cell-based therapies for disorders of the CNS

EXPERT OPINION ON THERAPEUTIC PATENTS. 2005 OCT; 15 (10): 1361-1376

176

1253

16431 Herbst M, Wanker EE

Therapeutic approaches to polyglutamine diseases: Combating protein misfolding and aggregation

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (20): 2543-2555

176

1254

18174 Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D

Treatment of dementia in Parkinsonian syndromes with cholinesterase inhibitors

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2007; 23 (6): 351-367

176

1255

18853 Giordano V, Peluso G, Iannuccelli M, Benatti P, Nicolai R, et al.

Systemic and brain metabolic dysfunction as a new paradigm for approaching alzheimer's dementia

NEUROCHEMICAL RESEARCH. 2007 APR; 32 (4-5): 555-567

176

1256

18973 Hipkiss AR

Could carnosine or related structures suppress Alzheimer's disease?

JOURNAL OF ALZHEIMERS DISEASE. 2007 MAY; 11 (2): 229-240

176

1257

21273 Naylor R, Richardson SJ, McAllan BM

Boom and bust: a review of the physiology of the marsupial genus Antechinus

JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY. 2008 JUL; 178 (5): 545-562

176

1258

23136 Camins A, Crespo-Biel N, Junyent F, Verdaguer E, Canudas AM, et al.

Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium

CURRENT DRUG METABOLISM. 2009 JUN; 10 (5): 433-447

176

1259

23419 Tovar-Y-Romo LB, Santa-Cruz LD, Tapia R

Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis

MOLECULAR NEURODEGENERATION. 2009 JUL 20; 4: Art. No. 31

176

1260

23606 Tan JMM, Wong ESP, Lim KL

Protein Misfolding and Aggregation in Parkinson's Disease

ANTIOXIDANTS & REDOX SIGNALING. 2009 SEP; 11 (9): 2119-2134

101

176

Date / Author / Journal

LCS

GCS

LCR

1261

25105 Kim EK, Choi EJ

Pathological roles of MAPK signaling pathways in human diseases

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 APR; 1802 (4): 396-405

176

1262

26544 Souter S, Lee G

Tubulin-Independent Tau in Alzheimer's Disease and Cancer: Implications for Disease Pathogenesis and Treatment

CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 697-707

176

1263

3905 HAAG ML, GLASS LF, FENSKE NA

MERKEL CELL-CARCINOMA - DIAGNOSIS AND TREATMENT

DERMATOLOGIC SURGERY. 1995 AUG; 21 (8): 669-683

175

1264

3930 IACANGELO AL, EIDEN LE

CHROMOGRANIN-A - CURRENT STATUS AS A PRECURSOR FOR BIOACTIVE PEPTIDES AND A GRANULOGENIC/SORTING FACTOR IN THE REGULATED SECRETORY PATHWAY

REGULATORY PEPTIDES. 1995 AUG 22; 58 (3): 65-88

111

175

1265

6102 Prusiner SB

The prion diseases

BRAIN PATHOLOGY. 1998 JUL; 8 (3): 499-513

137

175

1266

9110 Dodel RC, Berger K, Oertel WH

PHARMACOECONOMICS. 2001; 19 (10): 1013-1038

175

1267

9925 Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, et al.

Brain iron pathways and their relevance to Parkinson's disease

JOURNAL OF NEUROCHEMISTRY. 2001 OCT; 79 (2): 225-236

163

175

1268

10478 Borriello A, Roberto R, Della Ragione F, Iolascon A

Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma

HAEMATOLOGICA. 2002 FEB; 87 (2): 196-214

175

1269

13242 Rodrigo J, Fernandez-Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, et al.

Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice

NEUROSCIENCE. 2004; 128 (1): 73-89

175

1270

14190 Vekrellis K, Rideout HJ, Stefanis L

Neurobiology of alpha-synulein

MOLECULAR NEUROBIOLOGY. 2004 AUG; 30 (1): 1-21

140

175

Date / Author / Journal

LCS

GCS

LCR

1271

14390 Eberhardt O, Schulz JB

Gene therapy in Parkinson's disease

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 243-260

175

1272

18523 Lehericy S, Marjanska M, Mesrob L, Sarazin M, Kinkingnehun S

Magnetic resonance imaging of Alzheimer's disease

EUROPEAN RADIOLOGY. 2007 FEB; 17 (2): 347-362

175

1273

22200 Bakota L, Brandt R

LIVE-CELL IMAGING IN THE STUDY OF NEURODEGENERATION

INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 276. 2009; 276: 49-103

175

1274

22414 Manciocco A, Chiarotti F, Vitale A, Calamandrei G, Laviola G, et al.

The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: The case of Parkinson's disease

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2009 JAN; 33 (1): 18-32

175

1275

23195 Sanchez-Moreno C, Jimenez-Escrig A, Martin A

Stroke: roles of B vitamins, homocysteine and antioxidants

NUTRITION RESEARCH REVIEWS. 2009 JUN; 22 (1): 49-67

175

1276

23466 Bamburg JR, Bloom GS

Cytoskeletal Pathologies of Alzheimer Disease

CELL MOTILITY AND THE CYTOSKELETON. 2009 AUG; 66 (8): 635-649

175

1277

24284 Castro RE, Santos MMM, Gloria PMC, Ribeiro CJA, Ferreira DMS, et al.

Cell Death Targets and Potential Modulators in Alzheimer's Disease

CURRENT PHARMACEUTICAL DESIGN. 2010; 16 (25): 2851-2864

175

1278

24504 Kikis EA, Gidalevitz T, Morimoto RI

Protein Homeostasis in Models of Aging and Age-Related Conformational Disease

PROTEIN METABOLISM AND HOMEOSTASIS IN AGING. 2010; 694: 138-159

175

1279

25137 Nilsson P, Iwata N, Muramatsu S, Tjernberg LO, Winblad B, et al.

Gene therapy in Alzheimer's disease - potential for disease modification

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2010 APR; 14 (4): 741-757

175

1280

416 CROWNE DP

THE FRONTAL EYE FIELD AND ATTENTION

PSYCHOLOGICAL BULLETIN. 1983; 93 (2): 232-260

174

Date / Author / Journal

LCS

GCS

LCR

1281

1843 CAMERON RS, RAKIC P

GLIAL-CELL LINEAGE IN THE CEREBRAL-CORTEX - A REVIEW AND SYNTHESIS

GLIA. 1991; 4 (2): 124-137

330

174

1282

4277 AbiDargham A, Laruelle M, Charney D, Krystal J

Serotonin and schizophrenia: A review

DRUGS OF TODAY. 1996 MAR; 32 (2): 171-185

174

1283

9121 Maynard TM, Sikich L, Lieberman JA, LaMantia AS

Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia

SCHIZOPHRENIA BULLETIN. 2001; 27 (3): 457-476

174

1284

9271 Sieradzan KA, Mann DMA

The selective vulnerability of nerve cells in Huntington's disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2001 FEB; 27 (1): 1-21

174

1285

9935 Chiesa R, Harris DA

Prion diseases: What is the neurotoxic molecule?

NEUROBIOLOGY OF DISEASE. 2001 OCT; 8 (5): 743-763

174

1286

11520 Coppens P, Hungerford S, Yamaguchi S, Yamadori A

Crossed aphasia: An analysis of the symptoms, their frequency, and a comparison with left-hemisphere aphasia symptomatology

BRAIN AND LANGUAGE. 2002 DEC; 83 (3): 425-463

174

1287

13037 Britz-Cunningham SH, Adelstein SJ

Molecular targeting with radionuclides: State of the science

JOURNAL OF NUCLEAR MEDICINE. 2003 DEC; 44 (12): 1945-1961

174

1288

13598 Tuo JS, Bojanowski CM, Chan CC

Genetic factors of age-related macular degeneration

PROGRESS IN RETINAL AND EYE RESEARCH. 2004 MAR; 23 (2): 229-249

174

1289

15297 Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease

JOURNAL OF CLINICAL NEUROSCIENCE. 2005 APR; 12 (3): 221-230

174

1290

16655 Beda NV, Nedospasov AA

Inorganic nitric oxide metabolites participating in NO-dependent modifications of biopolymers

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY. 2006 JAN-FEB; 32 (1): 1-22

174

Date / Author / Journal

1291

Cognitive, affective, and psychiatric features of Parkinson's disease

CLINICS IN GERIATRIC MEDICINE. 2006 NOV; 22 (4): 773-+

174

1292

17898 Huang HC, Klein PS

Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease

CURRENT DRUG TARGETS. 2006 NOV; 7 (11): 1389-1397

174

1293

18020 Marsh ED, Brooks-Kayal AR, Porter BE

Seizures and antiepileptic drugs: Does exposure alter normal brain development ?

EPILEPSIA. 2006 DEC; 47 (12): 1999-2010

174

1294

19252 Tan EK, Skipper LM

Pathogenic mutations in Parkinson disease

HUMAN MUTATION. 2007 JUL; 28 (7): 641-653

174

1295

19282 Bohnen NI, Frey KA

Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders

MOLECULAR IMAGING AND BIOLOGY. 2007 JUL-AUG; 9 (4): 243-257

174

1296

20479 Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA

Polymeric nanoparticles for the drug delivery to the central nervous system

EXPERT OPINION ON DRUG DELIVERY. 2008 FEB; 5 (2): 155-174

174

1297

22804 Nakamura T, Lipton SA

Cell death: protein misfolding and neurodegenerative diseases

APOPTOSIS. 2009 APR; 14 (4): 455-468

174

1298

23379 Mueller S, Chang S

Pediatric Brain Tumors: Current Treatment Strategies and Future Therapeutic Approaches

NEUROTHERAPEUTICS. 2009 JUL; 6 (3): 570-586

174

1299

160 WURTZ RH, ALBANO JE

VISUAL-MOTOR FUNCTION OF THE PRIMATE SUPERIOR COLLICULUS

ANNUAL REVIEW OF NEUROSCIENCE. 1980; 3: 189-226

404

173

1300

972 DAMJANOV I

LECTIN CYTOCHEMISTRY AND HISTOCHEMISTRY

LABORATORY INVESTIGATION. 1987 JUL; 57 (1): 5-20

393

173

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records